Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
PCI
Manufacturing
PCI and ChiRhoClin partner to foil shortage of diagnostic drug
PCI Pharma Services and ChiRhoClin inked a deal to address the potential shortage of a critical diagnostic drug used in testing for pancreatic cancer.
Joseph Keenan
Nov 20, 2024 9:30am
PCI puts $365M-plus into multiple US, EU manufacturing projects
Sep 24, 2024 12:48pm
PCI Pharma to expand Welsh manufacturing site in oncology push
Jul 28, 2022 10:10am
PCI Pharma earmarks $100M to expand fill-finish operations
May 11, 2022 3:30pm
OliX allies with PCI to develop dermatological RNAi therapies
May 11, 2021 7:15am
Bayer, Takeda, Celltrion and more—FiercePharmaAsia
Aug 28, 2020 12:22pm
